Journal of Pathology Clinical Research

Papers
(The TQCC of Journal of Pathology Clinical Research is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
Contribution of tumour and immune cells to PD‐L1 expression as a predictive biomarker in metastatic triple‐negative breast cancer: exploratory analysis from KEYNOTE‐11939
Issue Information36
Issue Information34
31
NTRK gene aberrations in triple‐negative breast cancer: detection challenges using IHC, FISH, RT‐PCR, and NGS30
A novel telomere biology disease‐associated gastritis identified through a whole exome sequencing‐driven approach30
Issue Information30
Issue Information29
Tumor‐associated macrophages and risk of recurrence in stage III colorectal cancer23
PRR11 unveiled as a top candidate biomarker within the RBM3‐regulated transcriptome in pancreatic cancer23
Issue Information22
CRLF2 and IKZF1 abnormalities in Mexican children with acute lymphoblastic leukemia and recurrent gene fusions: exploring surrogate markers of signaling pathways18
Assessment of clinical trial protocols for pathology content using the SPIRIT‐Path guidelines highlights areas for improvement18
Digital image analysis allows objective stratification of patients with silent PIT1‐lineage pituitary neuroendocrine tumors17
Quick Annotator: an open‐source digital pathology based rapid image annotation tool17
The activation of EP300 by F11R leads to EMT and acts as a prognostic factor in triple‐negative breast cancers17
Characterizing the tumor microenvironment in rare renal cancer histological types16
Exosome‐derived ANXA9 functions as an oncogene in breast cancer15
More than just acral melanoma: the controversies of defining the disease15
Immune checkpoint CD161/LLT1‐associated immunological landscape and diagnostic value in oral squamous cell carcinoma15
Clinicopathological features and cancer transcriptomic profiling of poorly cohesive gastric carcinoma subtypes14
Correlation of PD‐L1 expression with CD8+ T cells and oxidative stress‐related molecules NRF2 and NQO1 in esophageal squamous cell carcinoma13
Large language models as a diagnostic support tool in neuropathology12
Do explainable AI (XAI) methods improve the acceptance of AI in clinical practice? An evaluation of XAI methods on Gleason grading12
Issue Information12
Association between individual Warburg‐related proteins and prognosis in colorectal cancer12
Tumor‐associated lymphocytes and macrophages are related to stromal elastosis and vascular invasion in breast cancer12
Deep learning‐based analysis of EGFR mutation prevalence in lung adenocarcinoma H&E whole slide images11
Breast cancer survival prediction using an automated mitosis detection pipeline11
Exploring prognostic biomarkers in pathological images of colorectal cancer patients via deep learning11
11
Preoperative systemic chemotherapy alters the histopathological growth patterns of colorectal liver metastases11
VEGFA gene variants are associated with breast cancer progression11
Identification and validation of NFIA as a novel prognostic marker in renal cell carcinoma10
10
Translational practice of fluorescence in situ hybridisation to identify neuroblastic tumours with TERT rearrangements9
9
Quantitative proteomics identifies biomarkers to distinguish pulmonary from head and neck squamous cell carcinomas by immunohistochemistry9
9
Optimization of deep learning models for the prediction of gene mutations using unsupervised clustering8
Radiotherapy biobanking: current landscape, opportunities, challenges, and future aspirations8
8
A robust model training strategy using hard negative mining in a weakly labeled dataset for lymphatic invasion in gastric cancer8
8
Issue Information8
First proficiency testing for NGS‐based and combined NGS‐ and FISH‐based detection of FGFR2 fusions in intrahepatic cholangiocarcinoma8
Transcription start site‐level expression of thyroid transcription factor 1 isoforms in lung adenocarcinoma and its clinicopathological significance8
Somatic mutations in four novel genes contribute to homologous recombination deficiency in breast cancer: a real‐world clinical tumor sequencing study7
The prostate tissue‐based telomere biomarker as a prognostic tool for metastasis and death from prostate cancer after prostatectomy7
Macrophage migration inhibitory factor (MIF) predicts survival in patients with clear cell renal cell carcinoma7
DecreasedCD11c‐positive dendritic cells in the tumor microenvironment predict double‐hit/triple‐hit genotype and survival in diffuse large B‐cell lymphoma7
Paediatric BCOR‐associated sarcomas with a novel long spliced internal tandem duplication of BCOR exon 157
Histopathological tumour microenvironment score independently predicts outcome in primary operable colorectal cancer6
KRT81 and HNF1A expression in pancreatic ductal adenocarcinoma: investigation of predictive and prognostic value of immunohistochemistry‐based subtyping6
The prognostic marker elastin correlates with epithelial–mesenchymal transition and vimentin‐positive fibroblasts in gastric cancer6
Issue Information6
A combination of stromal PD‐L1 and tumoral nuclear β‐catenin expression as an indicator of colorectal carcinoma progression and resistance to chemoradiotherapy in locally advanced rectal ca6
High cyclin E1 protein, but not gene amplification, is prognostic for basal‐like breast cancer6
Papillary thyroid carcinoma tall cell variant shares accumulation of mitochondria, mitochondrial DNA mutations, and loss of oxidative phosphorylation complex I integrity with oncocytic tumors6
0.77878212928772